Sniff away heart failure pressure? nasal spray trial explored
NCT ID NCT07375212
Summary
This study aimed to test if a single dose of a nasal spray medicine (bumetanide) could quickly reduce fluid pressure in the lungs and lower blood volume in people with heart failure. It planned to involve patients who already had special implanted devices to monitor their heart pressure from home. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE，CONGESTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Prisma Health
Greenville, South Carolina, 29605, United States
Conditions
Explore the condition pages connected to this study.